ArticleBritish journal of pharmacology2016

Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.

F L Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.